Noninvasive estimation of fibrosis in chronic viral hepatitis

Abstract

In chronic viral hepatitis the liver biopsy helps the clinician to decide when to start treatment and plan follow-up. However, the execution of a liver biopsy is associated with discomfort, and sampling error can lead to misinterpretation. Serum markers and transient elastography (TE) are being considered as surrogates to the liver biopsy. The noninvasive tests are considered equal in identifying significant fibrosis, but TE is superior in identifying cirrhosis.

Original languageEnglish
JournalUgeskrift for Laeger
Volume175
Issue number34
Pages (from-to)1877-1882
Number of pages6
ISSN0041-5782
Publication statusPublished - 19 Aug 2013

Fingerprint

Dive into the research topics of 'Noninvasive estimation of fibrosis in chronic viral hepatitis'. Together they form a unique fingerprint.

Cite this